• Maze Therapeutics (NASDAQ:MAZE) Earns Buy Rating from Analysts at Guggenheim

    Источник: Buzz FX / 25 фев 2025 10:50:20   America/New_York


    Maze Therapeutics (NASDAQ:MAZE) Earns Buy Rating from Analysts at Guggenheim Written by MarketBeat February 25, 2025 Share Link copied to clipboard. Stock analysts at Guggenheim assumed coverage on shares of Maze Therapeutics ( NASDAQ:MAZE
    Read more...
Опубликовать